Frontlight ResearchEarly access
Idiopathic pulmonary fibrosis trials in North Macedonia
1 trial · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
- Where
- Skopje
- Age
- 40 years and over
- People
- 240 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07516951 · EU 2024-514246-37-00